scholarly journals Piemonte

2012 ◽  
Vol 13 (2S) ◽  
pp. 52-54
Author(s):  
Roberto Gasparini ◽  
Donatella Panatto ◽  
Bruna Dirodi ◽  
Rosa Prato ◽  
Gianni Amunni ◽  
...  
Keyword(s):  
Cost Effectiveness ◽  
Cost Savings ◽  
Vaccination Strategy ◽  
Cost Effective ◽  
Genital Warts ◽  
Quadrivalent Vaccine ◽  
Protective Activity ◽  
Effectiveness Analysis ◽  
The Cost ◽  
Quadrivalent Vaccines

In Piemonte region 82% of women (aged 24-64) are screened regularly, meaning every 3 years. The analysis on cross-protective activity exercised by bivalent and quadrivalent vaccines shows that the bivalent vaccine could prevent more pre-cancerous lesions and cases of cervicocarcinoma than quadrivalent, and that the latter could prevent genital warts that are not prevented by bivalent. The major number of cases avoided by the bivalent make it possible to fully offset the cost savings related to warts associated with the quadrivalent vaccine. Furthermore, a cost-effectiveness analysis shows that, considering regional tariffs, the multiple cohort (12-year-old + 25-year-old women) vaccination strategy with a 90% coverage could prevent 33 cases of cervicocarcinoma and 15 related deaths more than the vaccination of only 12-year-old girls, and thus proves to be cost-effective (11,974 €/QALY).

scholarly journals Sardegna

2012 ◽  
Vol 13 (2S) ◽  
pp. 58-60
Author(s):  
Roberto Gasparini ◽  
Donatella Panatto ◽  
Bruna Dirodi ◽  
Rosa Prato ◽  
Gianni Amunni ◽  
...  
Keyword(s):  
Cost Effectiveness ◽  
Cost Savings ◽  
Vaccination Strategy ◽  
Cost Effective ◽  
Genital Warts ◽  
Quadrivalent Vaccine ◽  
Protective Activity ◽  
Effectiveness Analysis ◽  
The Cost ◽  
Quadrivalent Vaccines

In Sardegna region 75% of women (aged 24-64) are screened regularly, meaning every 3 years. The analysis on cross-protective activity exercised by bivalent and quadrivalent vaccines shows that the bivalent vaccine could prevent more pre-cancerous lesions and cases of cervicocarcinoma than quadrivalent, and that the latter could prevent genital warts that are not prevented by bivalent. The major number of cases avoided by the bivalent make it possible to fully offset the cost savings related to warts associated with the quadrivalent vaccine. Furthermore, a cost-effectiveness analysis shows that, considering regional tariffs, the multiple cohort (12-year-old + 25-year-old women) vaccination strategy with a 90% coverage could prevent 17 cases of cervicocarcinoma and 8 related deaths more than the vaccination of only 12-year-old girls, and thus proves to be cost-effective (10,841 €/QALY).

scholarly journals Trento

2012 ◽  
Vol 13 (2S) ◽  
pp. 67-69
Author(s):  
Roberto Gasparini ◽  
Donatella Panatto ◽  
Bruna Dirodi ◽  
Rosa Prato ◽  
Gianni Amunni ◽  
...  
Keyword(s):  
Cost Effectiveness ◽  
Cost Savings ◽  
Vaccination Strategy ◽  
Cost Effective ◽  
Genital Warts ◽  
Quadrivalent Vaccine ◽  
Protective Activity ◽  
Effectiveness Analysis ◽  
The Cost ◽  
Quadrivalent Vaccines

In the province of Trento 80% of women (aged 24-64) are screened regularly, meaning every 3 years. The analysis on cross-protective activity exercised by bivalent and quadrivalent vaccines shows that the bivalent vaccine could prevent more pre-cancerous lesions and cases of cervicocarcinoma than quadrivalent, and that the latter could prevent genital warts that are not prevented by bivalent. The major number of cases avoided by the bivalent make it possible to fully offset the cost savings related to warts associated with the quadrivalent vaccine. Furthermore, a cost-effectiveness analysis shows that, considering regional tariffs, the multiple cohort (12-year-old + 25-year-old women) vaccination strategy with a 90% coverage could prevent 5 cases of cervicocarcinoma and 2 related deaths more than the vaccination of only 12-year-old girls, and thus proves to be cost-effective (11,029 €/QALY).

scholarly journals Valle d’Aosta

2012 ◽  
Vol 13 (2S) ◽  
pp. 73-75
Author(s):  
Roberto Gasparini ◽  
Donatella Panatto ◽  
Bruna Dirodi ◽  
Rosa Prato ◽  
Gianni Amunni ◽  
...  
Keyword(s):  
Cost Effectiveness ◽  
Cost Savings ◽  
Vaccination Strategy ◽  
Cost Effective ◽  
Genital Warts ◽  
Quadrivalent Vaccine ◽  
Protective Activity ◽  
Effectiveness Analysis ◽  
The Cost ◽  
Quadrivalent Vaccines

In Valle d’Aosta region 89% of women (aged 24-64) are screened regularly, meaning every 3 years. The analysis on cross-protective activity exercised by bivalent and quadrivalent vaccines shows that the bivalent vaccine could prevent more pre-cancerous lesions and cases of cervicocarcinoma than quadrivalent, and that the latter could prevent genital warts that are not prevented by bivalent. The major number of cases avoided by the bivalent make it possible to fully offset the cost savings related to warts associated with the quadrivalent vaccine. Furthermore, a cost-effectiveness analysis shows that, considering regional tariffs, the multiple cohort (12-year-old + 25-year-old women) vaccination strategy with a 90% coverage could prevent 1 case of cervicocarcinoma more than the vaccination of only 12-year-old girls, and thus proves to be cost-effective (11,365 €/QALY).

scholarly journals Liguria

2012 ◽  
Vol 13 (2S) ◽  
pp. 40-42
Author(s):  
Roberto Gasparini ◽  
Donatella Panatto ◽  
Bruna Dirodi ◽  
Rosa Prato ◽  
Gianni Amunni ◽  
...  
Keyword(s):  
Cost Effectiveness ◽  
Cost Savings ◽  
Vaccination Strategy ◽  
Cost Effective ◽  
Genital Warts ◽  
Quadrivalent Vaccine ◽  
Protective Activity ◽  
Effectiveness Analysis ◽  
The Cost ◽  
Quadrivalent Vaccines

In Liguria region 80% of women (aged 24-64) are screened regularly, meaning every 3 years. The analysis on cross-protective activity exercised by bivalent and quadrivalent vaccines shows that the bivalent vaccine could prevent more pre-cancerous lesions and cases of cervicocarcinoma than quadrivalent, and that the latter could prevent genital warts that are not prevented by bivalent. The major number of cases avoided by the bivalent make it possible to fully offset the cost savings related to warts associated with the quadrivalent vaccine. Furthermore, a cost-effectiveness analysis shows that, considering regional tariffs, the multiple cohort (12-year-old + 25-year-old women) vaccination strategy with a 90% coverage could prevent 11 cases of cervicocarcinoma and 5 related deaths more than the vaccination of only 12-year-old girls, and thus proves to be cost-effective (11,122 €/QALY).

scholarly journals Bolzano

2012 ◽  
Vol 13 (2S) ◽  
pp. 22-24
Author(s):  
Roberto Gasparini ◽  
Donatella Panatto ◽  
Bruna Dirodi ◽  
Rosa Prato ◽  
Gianni Amunni ◽  
...  
Keyword(s):  
Cost Effectiveness ◽  
Cost Savings ◽  
Vaccination Strategy ◽  
Cost Effective ◽  
Genital Warts ◽  
Quadrivalent Vaccine ◽  
Protective Activity ◽  
Effectiveness Analysis ◽  
The Cost ◽  
Quadrivalent Vaccines

In the province of Bolzano 86% of women (aged 24-64) are screened regularly, meaning every 3 years. The analysis on cross-protective activity exercised by bivalent and quadrivalent vaccines shows that the bivalent vaccine could prevent more pre-cancerous lesions and cases of cervicocarcinoma than quadrivalent, and that the latter could prevent genital warts that are not prevented by bivalent. The major number of cases avoided by the bivalent make it possible to fully offset the cost savings related to warts associated with the quadrivalent vaccine. Furthermore, a cost-effectiveness analysis shows that, considering regional tariffs, the multiple cohort (12-year-old + 25-year-old women) vaccination strategy with a 90% coverage could prevent 4 cases of cervicocarcinoma and 2 related deaths more than the vaccination of only 12-year-old girls, and thus proves to be cost-effective (11,035 €/QALY).

scholarly journals Calabria

2012 ◽  
Vol 13 (2S) ◽  
pp. 25-27
Author(s):  
Roberto Gasparini ◽  
Donatella Panatto ◽  
Bruna Dirodi ◽  
Rosa Prato ◽  
Gianni Amunni ◽  
...  
Keyword(s):  
Cost Effectiveness ◽  
Cost Savings ◽  
Vaccination Strategy ◽  
Cost Effective ◽  
Genital Warts ◽  
Quadrivalent Vaccine ◽  
Protective Activity ◽  
Effectiveness Analysis ◽  
The Cost ◽  
Quadrivalent Vaccines

In Calabria region 56% of women (aged 24-64) are screened regularly, meaning every 3 years. The analysis on cross-protective activity exercised by bivalent and quadrivalent vaccines shows that the bivalent vaccine could prevent more pre-cancerous lesions and cases of cervicocarcinoma than quadrivalent, and that the latter could prevent genital warts that are not prevented by bivalent. The major number of cases avoided by the bivalent make it possible to fully offset the cost savings related to warts associated with the quadrivalent vaccine. Furthermore, a cost-effectiveness analysis shows that, considering regional tariffs, the multiple cohort (12-year-old + 25-year-old women) vaccination strategy with a 90% coverage could prevent 37 cases of cervicocarcinoma and 17 related deaths more than the vaccination of only 12-year-old girls, and thus proves to be cost-effective (9,767 €/QALY).

scholarly journals Toscana

2012 ◽  
Vol 13 (2S) ◽  
pp. 64-66
Author(s):  
Roberto Gasparini ◽  
Donatella Panatto ◽  
Bruna Dirodi ◽  
Rosa Prato ◽  
Gianni Amunni ◽  
...  
Keyword(s):  
Cost Effectiveness ◽  
Cost Savings ◽  
Vaccination Strategy ◽  
Cost Effective ◽  
Genital Warts ◽  
Quadrivalent Vaccine ◽  
Protective Activity ◽  
Effectiveness Analysis ◽  
The Cost ◽  
Quadrivalent Vaccines

In Toscana region 83% of women (aged 24-64) are screened regularly, meaning every 3 years. The analysis on cross-protective activity exercised by bivalent and quadrivalent vaccines shows that the bivalent vaccine could prevent more pre-cancerous lesions and cases of cervicocarcinoma than quadrivalent, and that the latter could prevent genital warts that are not prevented by bivalent. The major number of cases avoided by the bivalent make it possible to fully offset the cost savings related to warts associated with the quadrivalent vaccine. Furthermore, a cost-effectiveness analysis shows that, considering regional tariffs, the multiple cohort (12-year-old + 25-year-old women) vaccination strategy with a 90% coverage could prevent 27 cases of cervicocarcinoma and 12 related deaths more than the vaccination of only 12-year-old girls, and thus proves to be cost-effective (11,466 €/QALY).

scholarly journals Lombardia

2012 ◽  
Vol 13 (2S) ◽  
pp. 43-45
Author(s):  
Roberto Gasparini ◽  
Donatella Panatto ◽  
Bruna Dirodi ◽  
Rosa Prato ◽  
Gianni Amunni ◽  
...  
Keyword(s):  
Cost Effectiveness ◽  
Cost Savings ◽  
Vaccination Strategy ◽  
Cost Effective ◽  
Genital Warts ◽  
Quadrivalent Vaccine ◽  
Protective Activity ◽  
Effectiveness Analysis ◽  
The Cost ◽  
Quadrivalent Vaccines

In Lombardia region 75% of women (aged 24-64) are screened regularly, meaning every 3 years. The analysis on cross-protective activity exercised by bivalent and quadrivalent vaccines shows that the bivalent vaccine could prevent more pre-cancerous lesions and cases of cervicocarcinoma than quadrivalent, and that the latter could prevent genital warts that are not prevented by bivalent. The major number of cases avoided by the bivalent make it possible to fully offset the cost savings related to warts associated with the quadrivalent vaccine. Furthermore, a cost-effectiveness analysis shows that, considering regional tariffs, the multiple cohort (12-year-old + 25-year-old women) vaccination strategy with a 90% coverage could prevent 92 cases of cervicocarcinoma and 42 related deaths more than the vaccination of only 12-year-old girls, and thus proves to be cost-effective (10,919 €/QALY).

scholarly journals Puglia

2012 ◽  
Vol 13 (2S) ◽  
pp. 55-57
Author(s):  
Roberto Gasparini ◽  
Donatella Panatto ◽  
Bruna Dirodi ◽  
Rosa Prato ◽  
Gianni Amunni ◽  
...  
Keyword(s):  
Cost Effectiveness ◽  
Cost Savings ◽  
Vaccination Strategy ◽  
Cost Effective ◽  
Genital Warts ◽  
Quadrivalent Vaccine ◽  
Protective Activity ◽  
Effectiveness Analysis ◽  
The Cost ◽  
Quadrivalent Vaccines

In Puglia region 58% of women (aged 24-64) are screened regularly, meaning every 3 years. The analysis on cross-protective activity exercised by bivalent and quadrivalent vaccines shows that the bivalent vaccine could prevent more pre-cancerous lesions and cases of cervicocarcinoma than quadrivalent, and that the latter could prevent genital warts that are not prevented by bivalent. The major number of cases avoided by the bivalent make it possible to fully offset the cost savings related to warts associated with the quadrivalent vaccine. Furthermore, a cost-effectiveness analysis shows that, considering regional tariffs, the multiple cohort (12-year-old + 25-year-old women) vaccination strategy with a 90% coverage could prevent 70 cases of cervicocarcinoma and 31 related deaths more than the vaccination of only 12-year-old girls, and thus proves to be cost-effective (9,935 €/QALY).

scholarly journals Sicilia

2012 ◽  
Vol 13 (2S) ◽  
pp. 61-63
Author(s):  
Roberto Gasparini ◽  
Donatella Panatto ◽  
Bruna Dirodi ◽  
Rosa Prato ◽  
Gianni Amunni ◽  
...  
Keyword(s):  
Cost Effectiveness ◽  
Cost Savings ◽  
Vaccination Strategy ◽  
Cost Effective ◽  
Genital Warts ◽  
Quadrivalent Vaccine ◽  
Protective Activity ◽  
Effectiveness Analysis ◽  
The Cost ◽  
Quadrivalent Vaccines

In Sicilia region 64% of women (aged 24-64) are screened regularly, meaning every 3 years. The analysis on cross-protective activity exercised by bivalent and quadrivalent vaccines shows that the bivalent vaccine could prevent more pre-cancerous lesions and cases of cervicocarcinoma than quadrivalent, and that the latter could prevent genital warts that are not prevented by bivalent. The major number of cases avoided by the bivalent make it possible to fully offset the cost savings related to warts associated with the quadrivalent vaccine. Furthermore, a cost-effectiveness analysis shows that, considering regional tariffs, the multiple cohort (12-year-old + 25-year-old women) vaccination strategy with a 90% coverage could prevent 82 cases of cervicocarcinoma and 37 related deaths more than the vaccination of only 12-year-old girls, and thus proves to be cost-effective (10,534 €/QALY).

Sign in / Sign up

Export Citation Format

Share Document